Hofseth BioCare ASA filed its Annual on Mar 31, 2023 for the period ending Dec 31, 2022. In this report its auditor, Ernst & Young LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.12 NOK | +2.42% | -1.40% | -19.08% |
Mar. 14 | Hofseth BioCare ASA Announces Board Changes | CI |
Feb. 09 | Hofseth BioCare ASA Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-19.08% | 79.67M | |
-2.00% | 277B | |
-5.38% | 91.92B | |
-4.35% | 42.95B | |
+0.75% | 41.25B | |
+6.11% | 40.01B | |
+5.54% | 38.81B | |
-13.54% | 30.87B | |
-11.43% | 27.21B | |
+7.73% | 24.19B |
- Stock Market
- Equities
- HBC Stock
- News Hofseth BioCare ASA
- Hofseth BioCare ASA Auditor Raises 'Going Concern' Doubt